SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-19-015419
Filing Date
2019-10-11
Accepted
2019-10-11 17:00:15
Documents
1
Period of Report
2019-10-11

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 751400
  Complete submission text file 0001493152-19-015419.txt   752720
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-13789 | Film No.: 191148548
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences